CLASS II Drug recall · Reported 28 May 2014 · FDA Enforcement Report

Promethazine Hydrochloride Tablets, USP, 25 mg recalled

Zydus Pharmaceuticals USA is recalling Promethazine Hydrochloride Tablets, USP, 25 mg, distributed nationwide in the US. The recall was initiated on 8 May 2014 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #: MN9081, Expiry: 09/2015
NDC68382-040, 68382-041, 68382-042
Quantity recalled10,200 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1342-2014
FDA event ID
68285
Recalling firm
Zydus Pharmaceuticals USA, Pennington, NJ
Manufacturer
Zydus Pharmaceuticals USA Inc.
Classification
Class II
Status
Terminated
Recall initiated
8 May 2014
FDA classified
21 May 2014
Reported
28 May 2014
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

8 May 2014Recall initiated by company
21 May 2014Classified by FDA+13 days
28 May 2014Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Presence of Foreign Tablets: Presence of atenolol 25 mg tablet mixed into promethazine 25 mg tablet bottles.

Product as listed by the FDA

PROMETHAZINE HYDROCHLORIDE Tablets, USP, 25 mg, 100 Tablet Bottles, Rx Only. Manufactured by: Cadila Healthcared Ltd., India. Distributed by: Zydus Pharmaceuticals USA Inc., Pennington, NJ 08534. NDC: 68382-041-01

Where it was distributed

Nationwide

Nationwide

Questions about this recall

Why was it recalled?

Presence of Foreign Tablets: Presence of atenolol 25 mg tablet mixed into promethazine 25 mg tablet bottles.

Which lots are affected?

Lot #: MN9081, Expiry: 09/2015

Where was it sold?

Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Zydus Pharmaceuticals USA

All 41

Other Promethazine recalls

All 8